Business Models
- Top
- Company Profile
- Company Profile
- Business Models
Features of Our Business Models
Collaboration between the active pharmaceutical ingredient (API) business and the formulation product business
- Daito can ensure effective information sharing between its API business and formulation product business, leading to its high level of ability to collect and provide information.
- The Daito Group’s integrated process of manufacturing both APIs and formulation products enables high-quality products manufactured at a low cost.
- Development data are also shared between the API business and the formulation product business, enabling the Company to develop products that can serve market needs better.
Concentration of resources on drug development and manufacture
- Daito concentrates its management resources on drug development and manufacture by cutting sales costs.
- Without its own MRs, the Company has successfully kept down its fixed costs.
- The Company has limited its development pipeline to generic APIs and generic formulation products, which only entail lower development risks and lower development costs than those of new drugs.
A wide lineup of products
- Daito is engaged in not only the manufacture of generic drugs and over-the-counter (OTC) drugs but also the contract manufacture of new drugs and drugs for which the patents have already expired but that are still included in the Japanese health insurance price list. The Company boasts a wide lineup of products.
- Its business model of manufacturing and selling a broad category of products has enabled the Company to take advantage of a wide range of growth markets.
- Its involvement in manufacture contracted with major pharmaceutical manufacturers has brought the Company a high level of know-how for quality assurance and manufacture.
Enhanced trading function
- Daito can even sell external products by utilizing its own domestic and international networks to purchase those products from other companies.
- Since Daito was originally founded as a trading company, it boasts firmly established networks for purchase. The Company conducts solution business, providing customers with information necessary to them.
Businesses
API Business
APIs (active pharmaceutical ingredients) are raw materials from which pharmaceutical manufacturers make drugs. Generally, APIs refer to active substances contained in drugs.
We manufacture and sell our API products and import or purchase and sell external API products.
Pharmaceutical Product Business
Pharmaceutical products are finished drugs, which are divided into ethical drugs and non-prescription drugs.
We mainly manufacture and sell generic drugs, manufacture new drugs on a contract basis, and manufacture and sell OTC drugs.